MBOT
Closed
Microbot Medical Inc
2.49
-0.03 (-1.19%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 2.52
Day's Range: 2.43 - 2.54
Send
sign up or login to leave a comment!
When Written:
1.88
Microbot Medical Inc. is a medical device company that specializes in the development of micro-robotics technology. The company’s mission is to improve patient outcomes and quality of life by developing innovative medical devices that can be used in minimally invasive procedures. Microbot Medical Inc. is headquartered in Hingham, Massachusetts and was founded in 2010.
The company’s flagship product is the Self-Cleaning Shunt (SCS), which is designed to treat hydrocephalus, a condition that causes an accumulation of cerebrospinal fluid in the brain. The SCS is a miniature robot that can be implanted in the brain to help regulate the flow of cerebrospinal fluid, reducing the need for multiple surgeries to replace traditional shunts.
Microbot Medical Inc. is also developing other micro-robotic devices, including the TipCAT™, an endoluminal catheter system for the treatment of gastrointestinal (GI) diseases, and the LIBERTY™ robotic system, which is designed to assist surgeons in performing laparoscopic procedures.
The company has received several grants and awards for its innovative technology, including a $1.5 million grant from the Israel Innovation Authority and the European Union’s Horizon 2020 research and innovation program. Microbot Medical Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol MBOT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company’s flagship product is the Self-Cleaning Shunt (SCS), which is designed to treat hydrocephalus, a condition that causes an accumulation of cerebrospinal fluid in the brain. The SCS is a miniature robot that can be implanted in the brain to help regulate the flow of cerebrospinal fluid, reducing the need for multiple surgeries to replace traditional shunts.
Microbot Medical Inc. is also developing other micro-robotic devices, including the TipCAT™, an endoluminal catheter system for the treatment of gastrointestinal (GI) diseases, and the LIBERTY™ robotic system, which is designed to assist surgeons in performing laparoscopic procedures.
The company has received several grants and awards for its innovative technology, including a $1.5 million grant from the Israel Innovation Authority and the European Union’s Horizon 2020 research and innovation program. Microbot Medical Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol MBOT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!